New Drug Modalities – Asrar Qureshi’s Blog Post 1047
Asrar Qureshi’s blog discusses the Boston Consulting Group’s second annual report on the growth of new drug modalities. It highlights advancements in antibodies, recombinant products, cell therapies, gene therapies, and mRNA applications, emphasizing their implications for biopharma companies and patient care. The future of these modalities depends on their unique benefits and market speed.
